共 42 条
- [31] Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trialBJU INTERNATIONAL, 2014, 114 (03) : 418 - 426Chapple, ChristopherSchneider, TimHaab, FrancoisSun, FranklinWhelan, LaurenceScholfield, DavidDragon, ErikaMangan, Erin
- [32] OnabotulinumtoxinA Is Efficacious and Well Tolerated in Male Patients With Overactive Bladder and Urinary Incontinence: Placebo-Controlled Treatment Cycle 1 Results From a Pooled Analysis of Four Randomized TrialsTOXICON, 2022, 214 : S44 - S44Nitti, V.Ginsberg, D. A.Kohan, A.McCammond, K.Jenkins, B.Yushmanova, I.Boroujerdi, A.Chapple, C.
- [33] Initial Results From Summit: An Ongoing, 3-Part, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of Bezuclastinib in Adult Patients With Non-Advanced Systemic Mastocytosis (NonAdvSM)CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S429 - S429Bose, PrithvirajRein, Lindsay A. M.Oh, Stephen T.DeAngelo, Daniel J.Hunter, Anthony M.Akin, CemCastells, MarianaManning, MichaelHerrscher, RichardUstun, CelalettinKirshenbaum, ArnoldLivideanu, Cristina BulaiBoggs, Nathan A.Yi, Cecilia AranaSiebenhaar, FrankGeorge, Tracy I.Exter, BenjaminZhang, JennaPilla, AmandaJolin, HinaEaston, RachaelModena, Brian D.
- [34] Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placeboCONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 19High, Rachel A.Danford, Jill M.Shi, ZhaoyueKarmonik, ChristofKuehl, Thomas J.Bird, Erin T.Khavari, Rose
- [35] The Efficacy and Safety of OnabotulinumtoxinA or Solifenacin Compared with Placebo in Solifenacin Naive Patients with Refractory Overactive Bladder: Results from a Multicenter, Randomized, Double- Blind Phase 3b TrialJOURNAL OF UROLOGY, 2017, 198 (01) : 167 - 175Herschorn, SenderKohan, AlfredAliotta, PhilipMcCammon, KurtSriram, RajagopalanAbrams, StevenLam, WayneEveraert, Karel
- [36] A randomized double-blind placebo-controlled clinical trial of a product containing pumpkin seed extract and soy germ extract to improve overactive bladder-related voiding dysfunction and quality of lifeJOURNAL OF FUNCTIONAL FOODS, 2014, 8 : 111 - 117Shim, BongseokJeong, HyewonLee, SaraHwang, SeheeMoon, ByeongseokStorni, Charlotte
- [37] Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 TrialsJOURNAL OF UROLOGY, 2018, 200 (03) : 604 - 611Kaminetsky, JedFein, SeymourDmochowski, RogerMacDiarmid, ScottAbrams, StevenCheng, MariaWein, Alan
- [38] Botulinum toxin injections for Japanese patients with urinary incontinence caused by neurogenic detrusor overactivity: Clinical evaluation of onabotulinumtoxinA in a randomized, placebo-controlled, double-blind trial with an open-label extensionINTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 906 - 912Honda, MasashiYokoyama, OsamuTakahashi, RyosukeMatsuda, TatsumaNakayama, TakashiMogi, Takao
- [39] Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3x3 Crossover Phase II TrialINTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2175 - 2184Machida, KentaroKawayama, TomotakaKinoshita, MasaharuIchinose, MasakazuTsuda, TohruTakata, ShoheiKoto, HiroshiYoshida, MakotoAshihara, YoshinoriKawashima, MasaruSuna, HideakiInoue, Hiromasa
- [40] Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 studySCHIZOPHRENIA RESEARCH, 2016, 174 (1-3) : 126 - 131Isitt, John J.Nadipelli, Vijay R.Kouassi, AlexFava, MaurizioHeidbreder, Christian